LOGO
LOGO

Corporate News

Denali Therapeutics Down After Proposing To Sell $250 Million Of Shares

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

Shares of Denali Therapeutics Inc. (DNLI) are falling more than 9% Wednesday morning at $29.60.

The company today said it proposes offer for sale of $250 million of shares.

DNLI has traded in the range of $20.24-$56.08
in the last 52 weeks.

For comments and feedback contact: editorial@rttnews.com

Business News

Get Access to Premium Stock Alerts with RTT Intelligent Investor.
Global Economics Weekly Update - Jun 08-12, 2026

June 12, 2026 17:14 ET
Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.

RELATED NEWS